235 related articles for article (PubMed ID: 25784957)
1. In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches.
Li RJ; Wang YL; Wang QH; Wang J; Cheng MS
Comput Math Methods Med; 2015; 2015():418767. PubMed ID: 25784957
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional pharmacophore model for IMPDH inhibitors.
Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
[TBL] [Abstract][Full Text] [Related]
3. Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study.
Li RJ; Wang YL; Wang QH; Huang WX; Wang J; Cheng MS
SAR QSAR Environ Res; 2015; 26(5):421-38. PubMed ID: 25978645
[TBL] [Abstract][Full Text] [Related]
4. Role of salt bridge dynamics in inter domain recognition of human IMPDH isoforms: an insight to inhibitor topology for isoform-II.
Bairagya HR; Mukhopadhyay BP; Bera AK
J Biomol Struct Dyn; 2011 Dec; 29(3):441-62. PubMed ID: 22066532
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
7. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
8. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
9. Conserved water-mediated recognition and dynamics of NAD+ (carboxamide group) to hIMPDH enzyme: water mimic approach toward the design of isoform-selective inhibitor.
Bairagya HR; Mishra DK; Mukhopadhyay BP; Sekar K
J Biomol Struct Dyn; 2014; 32(8):1248-62. PubMed ID: 23829371
[TBL] [Abstract][Full Text] [Related]
10. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery.
Shu Q; Nair V
Med Res Rev; 2008 Mar; 28(2):219-32. PubMed ID: 17480004
[TBL] [Abstract][Full Text] [Related]
11. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
[TBL] [Abstract][Full Text] [Related]
13. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
[TBL] [Abstract][Full Text] [Related]
14. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
Schalk-Hihi C; Zhang YZ; Markham GD
Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
[TBL] [Abstract][Full Text] [Related]
15. In silico 3-D structure prediction and molecular docking studies of inosine monophosphate dehydrogenase from Plasmodium falciparum.
Raza M; Khan Z; Ahmad A; Raza S; Khan A; Mohammadzai IU; Zada S
Comput Biol Chem; 2017 Dec; 71():10-19. PubMed ID: 28957725
[TBL] [Abstract][Full Text] [Related]
16. Ligand and structure-based approaches for the identification of SIRT1 activators.
Vyas VK; Goel A; Ghate M; Patel P
Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
[TBL] [Abstract][Full Text] [Related]
17. A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.
Omolabi KF; Iwuchukwu EA; Agoni C; Olotu FA; Soliman MES
J Mol Model; 2021 Jan; 27(2):35. PubMed ID: 33423140
[TBL] [Abstract][Full Text] [Related]
18. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
20. Covalent inactivation of Mycobacterium thermoresistibile inosine-5'-monophosphate dehydrogenase (IMPDH).
Trapero A; Pacitto A; Chan DS; Abell C; Blundell TL; Ascher DB; Coyne AG
Bioorg Med Chem Lett; 2020 Jan; 30(2):126792. PubMed ID: 31757668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
